4 pillars of Stryker's growth strategy from CEO Kevin Lobo

Laura Dyrda -   Print  |

Since Stryker CEO Kevin Lobo took the helm in 2012, the company has nearly doubled revenues. Mr. Lobo discussed his strategy at the Chief Executive's Healthcare CEO Summit earlier this month.

Four key notes:

1. Stryker has an aggressive acquisition strategy that prizes add-ons to fit into its existing business so the company can strengthen its position in all lines. "We want to be absolute leaders in the field," Mr. Lobo said at the event.

2. Research and development is an important aspect of the company's acquisitions to ensure the technology is sound. Mr. Lobo reported Stryker spends around 6.5 percent of revenue on R&D, according to the report.

3. Mr. Lobo prizes de-risked buys and would rather spend extra on acquiring technology he knows will work and then apply Stryker's expertise to scale manufacturing.

4. Finally, Mr. Lobo attributed the company's success to the autonomy he gives divisional leaders to innovate and identify the best deals to present at headquarters.

More articles on orthopedics:
Medicare's bundled payments cut joint replacement spending by 1.6% — 5 study takeaways
Wisconsin health system settles orthopedic surgeon's kickback violation allegations for $10M: 5 details
NYC orthopedic surgeon’s office manager alleges doctor set her up for grand larceny arrest, charges: 5 details

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers